Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Deloitte
McKinsey
Mallinckrodt
Julphar
Citi
Federal Trade Commission
Medtronic
Novartis
Baxter

Generated: October 23, 2017

DrugPatentWatch Database Preview

ROBIMYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Robimycin, and what generic Robimycin alternatives are available?

Robimycin is a drug marketed by Robins Ah and is included in one NDA.

The generic ingredient in ROBIMYCIN is erythromycin. There are ninety-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the erythromycin profile page.

Summary for Tradename: ROBIMYCIN

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list42
Patent Applications: see list9,648
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ROBIMYCIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Robins Ah
ROBIMYCIN
erythromycin
TABLET, DELAYED RELEASE;ORAL061633-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Fish and Richardson
Accenture
Deloitte
Baxter
Dow
Cipla
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot